Medical cannabis and stroke

What stroke is A stroke is a medical emergency in which the blood supply to part of the brain is interrupted. There are two main types. Ischaemic stroke — about 85% of UK cases — is caused by a blood clot blocking an artery supplying the brain. Haemorrhagic stroke — about 15% — is caused […]
Medical cannabis for ALS (motor neuron disease)

What ALS is Amyotrophic lateral sclerosis (ALS), usually called motor neuron disease in the UK, causes progressive damage to the nerve cells that control movement, speech, swallowing and breathing. Cannabis research has examined symptom reports and animal models, but not a controlled treatment trial in people with ALS. Cannabis research on ALS (motor neuron disease) […]
Medical cannabis for Alzheimer’s and dementia

What Alzheimer's disease and dementia are Alzheimer’s disease is the most common cause of dementia, accounting for an estimated 60 to 70 per cent of cases. It is a progressive neurodegenerative condition characterised by the accumulation of extracellular beta-amyloid plaques and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein, accompanied by chronic neuroinflammation, synaptic loss, […]
Medical cannabis for diabetes and metabolic health

What diabetes and metabolic syndrome are Diabetes mellitus is a group of metabolic disorders defined by chronically elevated blood glucose (hyperglycaemia). Type 2 diabetes accounts for around 90% of UK cases and involves insulin resistance — cells become less responsive to insulin — combined with a progressive decline in insulin production by pancreatic beta cells. […]
Medical cannabis for HIV/AIDS

What HIV/AIDS is HIV attacks CD4 immune cells. Antiretroviral therapy can suppress the virus and prevent progression to AIDS, but people may still experience appetite loss, weight loss, neuropathic pain, nausea and sleep problems. The cannabis studies in this register concern those symptoms and patterns of use, not treatment of HIV infection. Cannabis research on […]
Medical cannabis for ME/CFS and fatigue symptoms

Practical UK patient guide to ME/CFS, fatigue symptoms, medical cannabis evidence limits, records, previous treatments, safety and specialist assessment.
Medical cannabis for Ehlers-Danlos and hypermobility-related pain

Practical UK patient guide to Ehlers-Danlos, hypermobility-related pain, medical cannabis evidence limits, records, previous treatments and specialist assessment.
Medical cannabis for autism: evidence, risks and assessment boundaries

Red-risk UK guide to autism, medical cannabis evidence limits, coexisting conditions, safeguarding, mental-health screening, consent and capacity.
Medical cannabis for Tourette’s and tic disorders

UK guide to Tourette’s, tic disorders and medical cannabis evidence limits, specialist assessment, ADHD, OCD, anxiety and safety screening.
Medical cannabis for Parkinson’s symptoms and tremor

UK guide to Parkinson’s symptoms, tremor and medical cannabis evidence limits, specialist assessment, falls risk, cognition and interactions.